Teva Launches Generic of Lilly Testosterone Drug in the U.S.

Aug 21, 2017

Teva Pharmaceutical Industries announces its U.S. launch of generic Axiron (testosterone) topical solution CIII, originally manufactured by Eli Lilly and Company.

Testosterone topical solution CIII is a prescription medicine used to treat adult males who have low
or no testosterone due to certain medical conditions. It is supplied in a metered dose pump with an
underarm applicator.

“We are pleased with the result in the district court, which has helped Teva add yet another product
to our industry-leading generic portfolio, providing savings to our customers and to patients,” said
Andy Boyer, Teva’s President and CEO, Global Generic Medicines, North America.

Axiron had annual sales of about $247 million in the U.S., according to IMS data as of May 2017.